Mikroglial Phagositoz ve Yönetmeliği: Parkinson Hastalığında Terapötik Bir Hedef?
Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?
DOI: 10.3389/fnmol.2018.00144PMID: 29755317
Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?
DOI: 10.3389/fnmol.2018.00144PMID: 29755317
Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson's Diseases <i>in Vitro</i> and <i>in Vivo</i>: Regulation of Redox Biology and Mitochondrial Function.
DOI: 10.3389/fnagi.2018.00121PMID: 29755339
Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.
DOI: 10.3389/fphar.2018.00422PMID: 29755356
New HSF1 inducer as a therapeutic agent in a rodent model of Parkinson's disease.
DOI: 10.1016/j.expneurol.2018.04.012PMID: 29704482
Botulinum Neurotoxin Injection for the Treatment of Recurrent Temporomandibular Joint Dislocation with and without Neurogenic Muscular Hyperactivity.
DOI: 10.3390/toxins10050174PMID: 29693593
Improved Bioavailability of Levodopa Using Floatable Spray-Coated Microcapsules for the Management of Parkinson's Disease.
DOI: 10.1007/s12017-018-8491-0PMID: 29696585
Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities.
DOI: 10.1016/j.cjtee.2018.02.003PMID: 29764704
Regulatable Lentiviral Hematopoietic Stem Cell Gene Therapy in a Mouse Model of Parkinson's Disease.
DOI: 10.1089/scd.2018.0030PMID: 29562865
Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.
DOI: 10.1007/s11011-018-0239-xPMID: 29681010
Human-induced pluripotent stem cells derived hematopoietic progenitor cells for treatment of hematopoietic failure among trauma hemorrhagic shock patients.
DOI: 10.1016/j.jcot.2018.04.009PMID: 30828191
TRPM2: a candidate therapeutic target for treating neurological diseases.
DOI: 10.1038/aps.2018.31PMID: 29671419
Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation.
DOI: 10.2147/tcrm.s163190PMID: 29713179
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.